These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 29310122)
61. Hypervirulent strains of Clostridium difficile. Cookson B Postgrad Med J; 2007 May; 83(979):291-5. PubMed ID: 17488855 [TBL] [Abstract][Full Text] [Related]
62. Clostridium difficile ribotype diversity at six health care institutions in the United States. Waslawski S; Lo ES; Ewing SA; Young VB; Aronoff DM; Sharp SE; Novak-Weekley SM; Crist AE; Dunne WM; Hoppe-Bauer J; Johnson M; Brecher SM; Newton DW; Walk ST J Clin Microbiol; 2013 Jun; 51(6):1938-41. PubMed ID: 23554188 [TBL] [Abstract][Full Text] [Related]
63. Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014-2019. Abdrabou AMM; Ul Habib Bajwa Z; Halfmann A; Mellmann A; Nimmesgern A; Margardt L; Bischoff M; von Müller L; Gärtner B; Berger FK Int J Med Microbiol; 2021 May; 311(4):151507. PubMed ID: 33915347 [TBL] [Abstract][Full Text] [Related]
64. A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1. Hoegh AM; Nielsen JB; Lester A; Friis-Møller A; Schønning K Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1073-9. PubMed ID: 21938539 [TBL] [Abstract][Full Text] [Related]
65. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Vedantam G; Clark A; Chu M; McQuade R; Mallozzi M; Viswanathan VK Gut Microbes; 2012; 3(2):121-34. PubMed ID: 22555464 [TBL] [Abstract][Full Text] [Related]
66. Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America. Aguayo C; Flores R; Lévesque S; Araya P; Ulloa S; Lagos J; Hormazabal JC; Tognarelli J; Ibáñez D; Pidal P; Duery O; Olivares B; Fernández J Epidemiol Infect; 2015 Oct; 143(14):3069-73. PubMed ID: 25687254 [TBL] [Abstract][Full Text] [Related]
67. Clostridium difficile infection: monoclonal or polyclonal genesis? Hell M; Permoser M; Chmelizek G; Kern JM; Maass M; Huhulescu S; Indra A; Allerberger F Infection; 2011 Oct; 39(5):461-5. PubMed ID: 21826436 [TBL] [Abstract][Full Text] [Related]
68. Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Hunt JJ; Ballard JD Microbiol Mol Biol Rev; 2013 Dec; 77(4):567-81. PubMed ID: 24296572 [TBL] [Abstract][Full Text] [Related]
69. To the Editor: Molecular epidemiology of toxigenic Clostridium difficile isolates in Korea. Cho SY; Nam Y; Soh YS; Park TS; Lee HJ Epidemiol Infect; 2014 Aug; 142(8):1651-2. PubMed ID: 24290036 [No Abstract] [Full Text] [Related]
71. Genomic Epidemiology of a Protracted Hospital Outbreak Caused by a Toxin A-Negative Clostridium difficile Sublineage PCR Ribotype 017 Strain in London, England. Cairns MD; Preston MD; Lawley TD; Clark TG; Stabler RA; Wren BW J Clin Microbiol; 2015 Oct; 53(10):3141-7. PubMed ID: 26179308 [TBL] [Abstract][Full Text] [Related]
72. A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strain. Wehrhahn MC; Keighley C; Kurtovic J; Knight DR; Hong S; Hutton ML; Lyras D; Wang Q; Leong R; Borody T; Edye M; Riley TV Anaerobe; 2019 Feb; 55():117-123. PubMed ID: 30500477 [TBL] [Abstract][Full Text] [Related]
73. Clostridium difficile infection: a worldwide disease. Burke KE; Lamont JT Gut Liver; 2014 Jan; 8(1):1-6. PubMed ID: 24516694 [TBL] [Abstract][Full Text] [Related]
74. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon. Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838 [TBL] [Abstract][Full Text] [Related]
75. Transition From PCR-Ribotyping to Whole Genome Sequencing Based Typing of Seth-Smith HMB; Biggel M; Roloff T; Hinic V; Bodmer T; Risch M; Casanova C; Widmer A; Sommerstein R; Marschall J; Tschudin-Sutter S; Egli A Front Cell Infect Microbiol; 2021; 11():681518. PubMed ID: 34141631 [No Abstract] [Full Text] [Related]
76. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gerding DN; Johnson S; Rupnik M; Aktories K Gut Microbes; 2014; 5(1):15-27. PubMed ID: 24253566 [TBL] [Abstract][Full Text] [Related]
77. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013. Davies KA; Ashwin H; Longshaw CM; Burns DA; Davis GL; Wilcox MH; Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27470194 [TBL] [Abstract][Full Text] [Related]
78. Toxigenic Clostridium difficile colonization among hospitalised adults; risk factors and impact on survival. Behar L; Chadwick D; Dunne A; Jones CI; Proctor C; Rajkumar C; Sharratt P; Stanley P; Whiley A; Wilks M; Llewelyn MJ J Infect; 2017 Jul; 75(1):20-25. PubMed ID: 28435086 [TBL] [Abstract][Full Text] [Related]
79. Origin, genomic diversity and microevolution of the Guerrero-Araya E; Meneses C; Castro-Nallar E; Guzmán D AM; Álvarez-Lobos M; Quesada-Gómez C; Paredes-Sabja D; Rodríguez C Microb Genom; 2020 May; 6(5):. PubMed ID: 32176604 [No Abstract] [Full Text] [Related]